DeepMed Research

THE GEORGE INSTITUTE

🇮🇳India

Country: 🇮🇳India

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic Shock

Phase 4

Completed

Conditions: Septic Shock

Interventions: Drug: Sterile air filled vial
Drug: Hydrocortisone

First Posted Date: 2011-10-07

Last Posted Date: 2017-12-12

Lead Sponsor: The George Institute

Target Recruit Count: 3800

Registration Number: NCT01448109

Locations: 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺
The George Institute for Global Health, Sydney, New South Wales, Australia
🇦🇺
Royal Brisbane and Women's Hospital, Herston, Queensland, Australia

and more 67 locations

Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)

Phase 3

Completed

Conditions: Ischemic Stroke
High Blood Pressure

Interventions: Drug: Low-dose rtPA
Drug: Standard-dose rtPA
Other: Intensive blood pressure (BP) lowering
Other: BP management policies

First Posted Date: 2011-08-24

Last Posted Date: 2021-10-13

Lead Sponsor: The George Institute

Target Recruit Count: 4587

Registration Number: NCT01422616

Locations: 🇦🇺
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study

Completed

Conditions: Diabetes Mellitus, Type 2

First Posted Date: 2009-07-30

Last Posted Date: 2014-05-19

Lead Sponsor: The George Institute

Target Recruit Count: 8494

Registration Number: NCT00949286

Locations: 🇦🇺
LCC 80 - Canberra Hospital, Garran, Australian Capital Territory, Australia
🇦🇺
LCC 76 - The Alfred Hospital, Melbourne, Victoria, Australia
🇦🇺
LCC 65 - Dandenong Hospital, Dandenong, Victoria, Australia

and more 169 locations

Crystalloid Versus Hydroxyethyl Starch Trials

Phase 3

Completed

Conditions: Intensive Care

Interventions: Drug: 6% Hydroxy-ethyl starch (130/0.4)
Drug: Saline

First Posted Date: 2009-07-08

Last Posted Date: 2012-11-16

Lead Sponsor: The George Institute

Target Recruit Count: 7000

Registration Number: NCT00935168

Locations: 🇦🇺
The George Institute for International Health, Sydney, New South Wales, Australia

The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial

Not Applicable

Completed

Conditions: Hypertension
Stroke
Intracerebral Hemorrhage

Interventions: Other: Blood pressure management policies

First Posted Date: 2008-07-16

Last Posted Date: 2013-12-13

Lead Sponsor: The George Institute

Target Recruit Count: 2839

Registration Number: NCT00716079

Locations: 🇫🇷
Hopital de Lariboisiere, Paris, France
🇧🇷
Regional Coordinating Centre Brazil, Sao Paulo, Brazil
🇨🇳
Regional Coordinating Centre China: The George Institute China, Beijing, Beijing, China

and more 59 locations

A Clinical Trial of IntensiVE Dialysis

Phase 4

Completed

Conditions: Uremia
Renal Replacement Therapy
Renal Dialysis
End Stage Renal Disease
End Stage Kidney Disease

Interventions: Procedure: haemodialysis

First Posted Date: 2008-04-01

Last Posted Date: 2019-12-03

Lead Sponsor: The George Institute

Target Recruit Count: 200

Registration Number: NCT00649298

Locations: 🇨🇳
Huaxi Hospital of Sichuan University, Chengdu, Sichuan, China
🇦🇺
Sydney Dialysis Centre, Sydney, New South Wales, Australia
🇦🇺
Sydney Adventist Hospital, Sydney, New South Wales, Australia

and more 37 locations

The Dietary Intervention in e-Shopping Trial

Not Applicable

Completed

Conditions: Behaviour

First Posted Date: 2006-07-14

Last Posted Date: 2006-07-14

Lead Sponsor: The George Institute

Target Recruit Count: 500

Registration Number: NCT00352508

Locations: 🇦🇺
The George Institute, Sydney, New South Wales, Australia

Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)

Phase 4

Completed

Conditions: Cerebrovascular Accidents
Diabetes Mellitus
Myocardial Infarction
Angina Pectoris

Interventions: Drug: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin
Behavioral: Health Promotion

First Posted Date: 2005-12-08

Last Posted Date: 2018-09-12

Lead Sponsor: The George Institute

Target Recruit Count: 3712

Registration Number: NCT00263393

Locations: 🇮🇳
Byrraju Foundation Primary Healthcare Centres in rural West Godavari and East Godavari Dstricts, Bhimavaram, Andhra Pradesh, India

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

Not Applicable

Completed

Conditions: CVA (Cerebrovascular Accident)
Cerebral Hemorrhage
Intracranial Hemorrhages

First Posted Date: 2005-09-26

Last Posted Date: 2008-06-26

Lead Sponsor: The George Institute

Target Recruit Count: 404

Registration Number: NCT00226096

Locations: 🇦🇺
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺
Royal Melbourne Hospital, Melbourne, Victoria, Australia

and more 16 locations

Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).

Phase 4

Completed

Conditions: Acute Renal Failure

Interventions: Procedure: "augmented" CRRT regimen

First Posted Date: 2005-09-22

Last Posted Date: 2009-02-27

Lead Sponsor: The George Institute

Target Recruit Count: 1508

Registration Number: NCT00221013

Locations: 🇦🇺
The Austin Hopsital, Heidelberg, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy